Screener
Moderna MRNA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Moderna’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001682852-26-000060
FAQ
- What is Moderna's operating lease liabilities (total)?
- Moderna (MRNA) reported operating lease liabilities (total) of $664M in Q1 2026.
- How has Moderna's operating lease liabilities (total) changed year-over-year?
- Moderna's operating lease liabilities (total) decreased by 2.6% year-over-year, from $682M to $664M.
- What is the long-term trend for Moderna's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Moderna's operating lease liabilities (total) has grown at a 45.3% compound annual growth rate (CAGR), from $103.39M to $670M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Moderna's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude